Cancer Suffers Defeat In A First: Experimental Dostarlimab Removes Cancer Tumours Completely, Know How
By D N Singh
It is indeed a big, big news that, medical experiments with medicine have produced a kind of miracle result to defeat cancer.
The experimental cancer treatment tried on a 12 person group with cancer have their disease (tumor) vanished completely after administration of a treatment drug, Dostarlimab.
It is an unprecedented success to be cheered about. Thanks to the US Food & Drug Administration which has gifted the wonder drug
Dostarlimab-gxly , viewed to be a drug candidate produced by GlaxoSmithKline.
In fact, the trial was first conducted by the Memorial Sloan Kettering Cancer Center in New York
In a New England Journal of Medicine it has been said that “Single dose dostarlimab was administered every three weeks for six months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery.”
And further good news that the ones had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery,” the study added
All the 12 people 12 patients who were given the course of treatment and a six months of follow-up care, tumours in all 12 patients had vanished completely.
Calling it an “unprecedented success” in the history of battle against cancer, Dr Kuis A Diaz from the Memorial Sloan Kettering Cancer Center was quoted in the New York Times saying, further that it is a great stride made in cancer treatment.
A year after, the patients were examined with positron-emission tomography (PET) scans, endoscopic evaluations, digital rectal examinations, and/or biopsy.
And in all 12 patients, no evidence was present of the tumours. And, interestingly, the persons who were selected had all undergone several other treatment procedures for colorectal cancer had no success.
